Corrigendum to "Dual targeting nanoparticles based on hyaluronic and folic acids as a promising delivery system of the encapsulated 4-Methylumbelliferone (4-MU) against invasiveness of lung cancer in vivo and in vitro" [Int. J. Biol. Macromol. 206 (2022) 467-480].